Cellular and Molecular Imaging Core (Diabetes Endocrinology Research Center)

Description

 

The primary goals of the University of Washington DERC Cellular and Molecular Imaging Core are to:

  • Provide state-of-the-art facilities and technical assistance for morphological and histochemical analyses to DERC investigators, obviating duplication of these instruments and resources in their own laboratories;
  • Train DERC investigators, postdoctoral fellows, and research personnel in the design and interpretation of morphological-based protocols for their diabetes-related research.
  • Assist DERC investigators with developing and implementing new histochemical and imaging techniques for their diabetes research.
Category of resources
  • Cell and /or tissue analysis (histology, pathology, cell sorting, cytometry, microscale imaging)
  • Microscopy (light, electron, fluorescent, etc.)
  • Imaging (‘macro’ scale- small animal, human)
Services provided
  • Self-service access to instruments/equipment (with appropriate training)
  • Access to technology services (i.e. microarray, specimen analysis)
  • Consultations (i.e. study design, experiment design)
  • Training (instruments, software and/or methods)
  • Professional service (i.e. analysis, report writing, manuscript review)
Specialty equipment/services
Web address(es) Cellular and Molecular Imaging Core (Diabetes Endocrinology Research Center)
Fee information for Cellular and Molecular Imaging Core (Diabetes Endocrinology Research Center)
Location Washington - University of Washington -Main Campus
Building 1/Rm 517, VAPSMC
Manager or contact Denis Bask
Users who may access
  • Only individuals funded by a specific funding source
  • Anyone from this institution
This listing was last modified on June 30, 2009.

The information above was provided by the individual resource center. To change your center's information, please send a message with details (including resource center name and all changes). To add a new resource, submit a resource center for consideration.